Latest Price,countries

Liraglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), has become a significant therapeutic agent for managing type 2 diabetes and chronic weight management. Its availability and accessibility, however, can vary considerably across different countries. Understanding the global liraglutide availability by country is crucial for patients, healthcare providers, and pharmaceutical distributors. This article aims to provide a detailed overview of where liraglutide is currently accessible, considering brand names, generic options, and any reported supply fluctuations.

Global Accessibility and Brand Names:

Globally, liraglutide medicine is currently accessible in over 100 countries. The primary brand name associated with liraglutide for diabetes management is Victoza, while Saxenda is the brand name for its use in weight management. These medications are manufactured by Novo Nordisk. However, the landscape is evolving with the introduction of generic versions and biosimil products.

Key Countries and Regions with Liraglutide Availability:

* North America: In the United States, Victoza and Saxenda have been available for some time. Notably, Teva has liraglutide injection available, and Hikma received FDA approval and launched its generic version of Victoza (liraglutide) in December 2024. Generic liraglutide prescription online for weight loss is also a consideration for some individuals.

* Europe: Liraglutide was approved for medical use in the European Union in 2009. The European Medicines Agency (EMA) plays a significant role in regulating its availability. While Victoza and Saxenda are generally available, there have been reports of shortages. The EMA has recommended that member countries prioritize GLP-1 RAs for specific patient groups. Biocon Limited launched its GLP-1, liraglutide, in the Netherlands in December 2025. Product availability may vary between countries within Europe, and specific guidance on Saxenda ema status is important.

* Asia: India has seen the introduction of biosimilar liraglutide. Glenmark launched Lirafit™, a biosimilar of liraglutide, in India in January 2024, aiming for a more affordable option. Liraglutide is also available in countries like Japan and Malaysia.

* Other Regions: Liraglutide is also accessible in Canada, Brazil, and Mexico. The market opportunity for liraglutide for obesity in Mexico is estimated to be substantial.

Understanding Liraglutide Shortages and Supply Fluctuations:

Recent years have seen intermittent liraglutide shortages reported in various regions. These shortages are often attributed to a combination of factors, including manufacturing delays, increased global demand, and commercial decisions. For instance, Victoza has faced shortages due to manufacturing delays by Novo Nordisk, although Saxenda remained available from this manufacturer. The European Medicines Agency (EMA) has also reported Victoza shortages starting in 2023 and 2024 due to temporary supply reductions and increased demand.

The FDA shortage list is a critical resource for tracking drug availability in the US. Information regarding Victoza shortage 2025 and Saxenda shortage 2025 is essential for proactive management. Some reports indicate a "reduction in supply until supply is exhausted" for liraglutide, suggesting a temporary discontinuation or significant reduction rather than a complete withdrawal in certain instances. It's important to note that Victoza discontinued is not a universal status, and availability can be country-specific and subject to change.

Generic and Biosimilar Liraglutide:

The emergence of generic and biosimilar liraglutide is a significant development, potentially increasing accessibility and reducing costs. Teva has launched a generic version of Saxenda® (liraglutide injection), marking the first generic GLP-1 indicated for weight loss in the US. Hikma has also launched its generic liraglutide in the US. In India, Glenmark's Lirafit™ is a notable biosimilar. Information on liraglutide generic cost is becoming increasingly relevant as these options become more widespread. The FDA approval status, generic manufacturers, and patent expirations are key factors influencing the availability of generic liraglutide.

Navigating Liraglutide Availability:

For individuals seeking liraglutide, it is vital to consult with their healthcare provider. Here are proven tools and tips to locate liraglutide in stock:

* Pharmacy Checks: Directly inquire with local pharmacies about the availability of Victoza, Saxenda, or generic **lir